Bio for Alexandra Potter, Ph.D. Alexandra Potter, Ph.D.Research Assistant ProfessorDepartment of Psychiatry Contact Information E-mail: Alexandra.Potter@uvm.eduOffice Location: 1 South Prospect Street, MS 446AR6, Burlington, VT 05401 Education2001 Pre-Doctoral Internship, Behavior Therapy and Psychotherapy Center, Department of Psycholoy, University of Vermont1996-2003 Graduate, University of Vermont, Department of Psychology, Ph.D. in Clinical Psychology1986-1990 Undergraduate, University of Vermont, Burlington, Vermont, Bachelor of Arts (BA) in Psychology, cum laudeResearch GrantsONGOING GRANTS: Title: Adolescent Brains, Nicotine and Endogenoius PrototoxinsSponsor: NIH/NIDAGrant Number: 1 RC1 DA028173-01Dates: September 2009-August 2011Role: Co-Investigator (PI: Rae Nishi, Ph.D.) Title: Neurobiological Underpinnings of Cognitive Deficits in Neurodevelopmental DisordersSponsor: NIH/NIMHGrant Number: 1K23MH079216Dates: April 2009-December 2013Role: Principal Investigator Title: Cholinergic Contributions to Social Information Processing in Prodromal SchizophreniaSponsor: NARSADDates: January 2010-December 2012Role: Principal Investigator Title: Clinical Research Loan Repayment ProgramSponsor: National Institutes of Health (NIH)Dates: September 2004 -December 2007, September 2008-December 2010, September 2010- December 2011Role: Clinical Researcher Loan Repayment RecipientRECENTLY COMPLETED GRANTS Title: Nicotine Treatment of Impulsivity in Parkinson's Disease: A Pilot StudySponsor: Parkinson Study Group (PSG)Grant ID: Mentored Clinical Research Award (Boyd)Dates: July 2010-June 2011Role: Co-Mentor Title: The Functional Neuroanatomy of Acute Nicotinic Modulation of Impulsivity in WomenSponsor: NIH/NIDADates: April 2008-March 2009Role: Principal Investigator Title: The Effect of TC1734 on Behavioral Inhibition in Attention-Deficit/Hyperactivity Disorder (ADHD)Sponsor: Targacept Inc.Dates: May 2008 - December 2009Role: Co-Principal Investigator Title: Correlates of Impulsivity in Young AdultsSponsor: University of Vermont College of MedicineDates: January 2006- December 2008Role: Principal Investigator Title: An Open Label, Behavioral-Treatment Controlled Evaluation of the Effects of Extended Release Methyphenidate (Ritalin LA) on the Frequency of Cytogenetic Abnormalities in Children 6-12 Years of Age with Attention-Deficit/Hyperactivity Disorder (ADHD)Sponsor: Novartix Inc.Dates: September 2006 - June 2009Role: Principle InvestigatorAwards and Honors2005 Travel Award Fellow, Society of Biological Psychiatry2003 Graduate Student Travel Fellowship, University of Vermont Graduate College1996 Member Phi Beta Kappa1990 John Dewey Award for excellence in undergraduate researchPublicationsPotter, AS., Ryan, K., Newhouse, PA (2009). Effects of acute ultra-low dose mecamylamine on cognition in adult Attention-Deficit/Hyperactivity Disorder (ADHD). Human Psychopharmacology: Clinical and Experimental, 24:309-317.Potter, A and Newhouse P. (2008). Acute nicotine improves cognitive deficits in young adults with Attention-Deficit/Hyperactivity Disorder. Pharmacology Biochemistry and Behavior, 88(4) 407-417.Potter, A., Newhouse, P., Bucci, D. (2006). Central nicotinic cholinergic systems: A role in the cognitive dysfunction in Attention-Deficit/Hyperactivity Disorder? Behavioral Brain Research, 175(2) 201-211.MacLeod, J., Potter, A., Simoni, M., Bucci, D. (2006). Nicotine administration enhances conditioned inhibition in rats. European Journal of Pharmacology, 551(1-3) 76-79.Singh, A., Potter, A., Newhouse, P. (2004). Nicotinic acetylcholine receptor system and neuropsychiatric disorders. IDrugs, 7(12) 1096-1103.To view more of Dr. Potter's publications, please visit PubMed.